BeefySignals Stock Spotlight: DaVita Inc. (DVA) 🏥

Pick recommended on: 20.02.2026

Hey, Beefies! Our Quant/AI stock-picking strategy uses advanced data models to make unbiased decisions based on real performance. Each week, we spotlight a standout pick we have offered to you and this week, we're putting the spotlight on DaVita Inc. (DVA).

💰 Valuation:
DVA trades at a compelling valuation, with its forward P/E ratio at 11, significantly cheaper than the sector median of 22. This indicates that DVA is undervalued compared to its peers, providing a potential opportunity for investors.

📈 Growth:
Although some growth metrics show slower expansion compared to the sector, DVA's forward long-term EPS growth of 26% vastly exceeds the sector's 11%, highlighting strong earnings growth potential over the next few years.

💼 Profitability:
DVA demonstrates strong profitability, with an EBITDA margin of 20%, significantly outperforming the sector's 11%. This suggests efficient operations and robust profit generation.

📉 Momentum:
DVA's stock momentum is robust, with a three-month price performance of 28%, well above the sector's decline of 9%, indicating strong investor interest and confidence in the stock.

🔮 Revisions:
Earnings revisions are favorable, with seven upward revisions and no downward revisions in the last three months, suggesting analysts are optimistic about DVA's future earnings prospects.

📊 Charting:
DVA is trading well above key moving averages, maintaining a strong bullish structure while the broader sector has declined, a clear sign of relative strength and sustained institutional interest.

🚀 Summary:
DaVita Inc. (DVA) offers a compelling combination of attractive valuation, strong profitability, and positive earnings revisions, coupled with solid momentum. These factors underpin its Buy rating, making it an appealing choice for investors seeking value and growth potential in the healthcare sector.

🐂 Stay Beefy. Stay Bullish! 🐂

Follow us on